{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:56:58Z","timestamp":1789628218870,"version":"build-2803163510"},"reference-count":101,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["219588Z\/19\/Z"],"award-info":[{"award-number":["219588Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.omtn.2024.102424","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T19:27:06Z","timestamp":1734031626000},"page":"102424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Harnessing defective interfering particles and lipid nanoparticles for effective delivery of an anti-dengue virus RNA therapy"],"prefix":"10.1016","volume":"36","author":[{"given":"Min-Hsuan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramila","family":"Maniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron R.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Suhrbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy Wales-","family":"Earl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaman","family":"Tayyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel A.J.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3690-0150","authenticated-orcid":false,"given":"David","family":"Harrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2024.102424_bib1","unstructured":"World Health Organization Disease Outbreak News; Dengue\u00a0\u2013 Global situation. (2023). https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2023-DON498."},{"key":"10.1016\/j.omtn.2024.102424_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8010063","article-title":"A Review on Dengue Vaccine Development","volume":"8","author":"Deng","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.omtn.2024.102424_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40506-023-00263-w","article-title":"Dengue: Update on Clinically Relevant Therapeutic Strategies and Vaccines","volume":"15","author":"Palanichamy Kala","year":"2023","journal-title":"Curr. Treat. Options Infect. Dis."},{"key":"10.1016\/j.omtn.2024.102424_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.virol.2014.08.013","article-title":"Sub-genomic RNA of defective interfering (D.I.) dengue viral particles is replicated in the same manner as full length genomes","volume":"468\u2013470","author":"Li","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2024.102424_bib5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s42003-021-02064-7","article-title":"Dengue virus-free defective interfering particles have potent and broad anti-dengue virus activity","volume":"4","author":"Li","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.omtn.2024.102424_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03949-22","article-title":"Defective Interfering Particles with Broad-Acting Antiviral Activity for Dengue, Zika, Yellow Fever, Respiratory Syncytial and SARS-CoV-2 Virus Infection","volume":"10","author":"Lin","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.omtn.2024.102424_bib7","article-title":"Defective interfering viral particles in acute dengue infections","volume":"6","author":"Li","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2024.102424_bib8","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/s41564-019-0465-y","article-title":"Defective viral genomes are key drivers of the virus-host interaction","volume":"4","author":"Vignuzzi","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.omtn.2024.102424_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1146\/annurev-virology-092818-015652","article-title":"The Impact of Defective Viruses on Infection and Immunity","volume":"6","author":"Genoyer","year":"2019","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.omtn.2024.102424_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/226325a0","article-title":"Defective viral particles and viral disease processes","volume":"226","author":"Huang","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102424_bib11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1743-422X-8-212","article-title":"Defective interfering virus protects elderly mice from influenza","volume":"8","author":"Scott","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.omtn.2024.102424_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049394","article-title":"Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza A virus and allows protective immunity to be established","volume":"7","author":"Dimmock","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2024.102424_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01786-18","article-title":"A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome","volume":"93","author":"Kupke","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102424_bib14","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1038\/s41467-021-22341-7","article-title":"Defective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hosts","volume":"12","author":"Rezelj","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102424_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009110","article-title":"Defective viral genomes from chikungunya virus are broad-spectrum antivirals and prevent virus dissemination in mosquitoes","volume":"17","author":"Levi","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2024.102424_bib16","doi-asserted-by":"crossref","first-page":"6022","DOI":"10.1016\/j.cell.2021.11.004","article-title":"Identification of a therapeutic interfering particle-A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance","volume":"184","author":"Chaturvedi","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2024.102424_bib17","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204624119","article-title":"A single-administration therapeutic interfering particle reduces SARS-CoV-2 viral shedding and pathogenesis in hamsters","volume":"119","author":"Chaturvedi","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102424_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/science.adn5866","article-title":"Engineered deletions of HIV replicate conditionally to reduce disease in nonhuman primates","volume":"385","author":"Pitchai","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.omtn.2024.102424_bib19","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1016\/j.vaccine.2011.01.102","article-title":"A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in\u00a0vivo","volume":"29","author":"Easton","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2024.102424_bib20","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1128\/JVI.03193-13","article-title":"Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?","volume":"88","author":"Dimmock","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102424_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/v15091872","article-title":"Broad-Spectrum Antiviral Activity of Influenza A Defective Interfering Particles against Respiratory Syncytial, Yellow Fever, and Zika Virus Replication In\u00a0Vitro","volume":"15","author":"Pelz","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.omtn.2024.102424_bib22","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.3390\/cells10071756","article-title":"Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In\u00a0Vitro through Stimulation of Innate Immunity","volume":"10","author":"Rand","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.omtn.2024.102424_bib23","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1016\/j.cell.2021.11.023","article-title":"A defective viral genome strategy elicits broad protective immunity against respiratory viruses","volume":"184","author":"Xiao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2024.102424_bib24","doi-asserted-by":"crossref","first-page":"16303","DOI":"10.1073\/pnas.1005077107","article-title":"Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing","volume":"107","author":"Baum","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102424_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.595390","article-title":"Defective Interfering Genomes and the Full-Length Viral Genome Trigger RIG-I After Infection With Vesicular Stomatitis Virus in a Replication Dependent Manner","volume":"12","author":"Linder","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2024.102424_bib26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.celrep.2018.06.047","article-title":"RIG-I Recognizes the 5' Region of Dengue and Zika Virus Genomes","volume":"24","author":"Chazal","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2024.102424_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003703","article-title":"Defective viral genomes arising in\u00a0vivo provide critical danger signals for the triggering of lung antiviral immunity","volume":"9","author":"Tapia","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2024.102424_bib28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","article-title":"RIG-I-like receptors: their regulation and roles in RNA sensing","volume":"20","author":"Rehwinkel","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtn.2024.102424_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00493-23","article-title":"Influenza Defective Interfering Virus Promotes Multiciliated Cell Differentiation and Reduces the Inflammatory Response in Mice","volume":"97","author":"Wang","year":"2023","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102424_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005122","article-title":"Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans","volume":"11","author":"Sun","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2024.102424_bib31","doi-asserted-by":"crossref","first-page":"S460","DOI":"10.1093\/infdis\/jiz564","article-title":"Inhibition of Nipah Virus by Defective Interfering Particles","volume":"221","author":"Welch","year":"2020","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.omtn.2024.102424_bib32","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180087","article-title":"Immune responses to dengue virus in the skin","volume":"8","author":"Rathore","year":"2018","journal-title":"Open Biol."},{"key":"10.1016\/j.omtn.2024.102424_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01314622","article-title":"Dengue virus infection of human skin fibroblasts in\u00a0vitro production of IFN-beta, IL-6 and GM-CSF","volume":"124","author":"Kurane","year":"1992","journal-title":"Arch. Virol."},{"key":"10.1016\/j.omtn.2024.102424_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03586-22","article-title":"Discrepant Activation Pattern of Inflammation and Pyroptosis Induced in Dermal Fibroblasts in Response to Dengue Virus Serotypes 1 and 2 and Nonstructural Protein 1","volume":"11","author":"Wei","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.omtn.2024.102424_bib35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jmv.21051","article-title":"Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells","volume":"80","author":"Kou","year":"2008","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.omtn.2024.102424_bib36","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1086\/518007","article-title":"Dengue virus infects macrophages and dendritic cells in a mouse model of infection","volume":"195","author":"Kyle","year":"2007","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.omtn.2024.102424_bib37","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1084\/jem.146.1.218","article-title":"Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in\u00a0vitro infection","volume":"146","author":"Halstead","year":"1977","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtn.2024.102424_bib38","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.chom.2010.01.004","article-title":"Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease","volume":"7","author":"Zellweger","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.omtn.2024.102424_bib39","doi-asserted-by":"crossref","first-page":"12138","DOI":"10.1128\/JVI.00375-12","article-title":"Trafficking and replication patterns reveal splenic macrophages as major targets of dengue virus in mice","volume":"86","author":"Prestwood","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102424_bib40","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.ymthe.2021.05.004","article-title":"A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19","volume":"29","author":"Idris","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102424_bib41","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood-2009-04-214957","article-title":"Preclinical characterization of the selective JAK1\/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms","volume":"115","author":"Quintas-Cardama","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2024.102424_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000261","article-title":"Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus","volume":"5","author":"Riggs","year":"2018","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.omtn.2024.102424_bib43","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"Muller","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.omtn.2024.102424_bib44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.antiviral.2015.08.013","article-title":"Animal models for studying dengue pathogenesis and therapy","volume":"123","author":"Chan","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.omtn.2024.102424_bib45","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1462-5822.2008.01277.x","article-title":"Human TLR3 recognizes dengue virus and modulates viral replication in\u00a0vitro","volume":"11","author":"Tsai","year":"2009","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.omtn.2024.102424_bib46","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.4049\/jimmunol.177.10.7114","article-title":"Flavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition","volume":"177","author":"Wang","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtn.2024.102424_bib47","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1128\/JVI.01080-07","article-title":"Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity","volume":"82","author":"Loo","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102424_bib48","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fimmu.2019.00325","article-title":"Regulating IRFs in IFN Driven Disease","volume":"10","author":"Jefferies","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2024.102424_bib49","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.celrep.2017.10.054","article-title":"An IRF-3-IRF-5-and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses","volume":"21","author":"Carlin","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2024.102424_bib50","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-virology-092818-015756","article-title":"Interferon-Stimulated Genes: What Do They All Do?","volume":"6","author":"Schoggins","year":"2019","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.omtn.2024.102424_bib51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.freeradbiomed.2022.11.037","article-title":"Differential expression of interferon inducible protein: Guanylate binding protein (GBP1\u00a0& GBP2) in severe dengue","volume":"194","author":"Mariappan","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.omtn.2024.102424_bib52","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/1743-422X-9-292","article-title":"Guanylate-binding protein 1 participates in cellular antiviral response to dengue virus","volume":"9","author":"Pan","year":"2012","journal-title":"Virol. J."},{"key":"10.1016\/j.omtn.2024.102424_bib53","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/1743-422X-8-468","article-title":"ISG15 facilitates cellular antiviral response to dengue and west nile virus infection in\u00a0vitro","volume":"8","author":"Dai","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.omtn.2024.102424_bib54","doi-asserted-by":"crossref","first-page":"8035","DOI":"10.4049\/jimmunol.0902728","article-title":"Distinct antiviral roles for human 2',5'-oligoadenylate synthetase family members against dengue virus infection","volume":"183","author":"Lin","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtn.2024.102424_bib55","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1128\/JVI.02199-09","article-title":"Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections","volume":"84","author":"Jiang","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102424_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051033","article-title":"BST2\/tetherin inhibits dengue virus release from human hepatoma cells","volume":"7","author":"Pan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2024.102424_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011286","article-title":"CMPK2 restricts Zika virus replication by inhibiting viral translation","volume":"19","author":"Pawlak","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2024.102424_bib58","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1128\/JVI.80.9.4501-4509.2006","article-title":"Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in\u00a0vivo","volume":"80","author":"Ank","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102424_bib59","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1016\/S0021-9258(18)32242-7","article-title":"Interferon induction of fibroblast proteins with guanylate binding activity","volume":"258","author":"Cheng","year":"1983","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2024.102424_bib60","first-page":"4518","article-title":"Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation","volume":"8","author":"Staeheli","year":"1988","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2024.102424_bib61","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1074-7613(03)00296-6","article-title":"The IL-12 family of heterodimeric cytokines: new players in the regulation of T\u00a0cell responses","volume":"19","author":"Trinchieri","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2024.102424_bib62","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtn.2024.102424_bib63","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/eji.202048933","article-title":"Zbtb10 transcription factor is crucial for murine cDC1 activation and cytokine secretion","volume":"51","author":"Smita","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omtn.2024.102424_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0002598","article-title":"Facing the escalating burden of dengue: Challenges and perspectives","volume":"3","author":"Malavige","year":"2023","journal-title":"PLOS Glob. Public Health"},{"key":"10.1016\/j.omtn.2024.102424_bib65","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1038\/s41467-024-50437-3","article-title":"Pan-serotype dengue virus inhibitor JNJ-A07 targets NS4A-2K-NS4B interaction with NS2B\/NS3 and blocks replication organelle formation","volume":"15","author":"Kiemel","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102424_bib66","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41586-021-03990-6","article-title":"A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction","volume":"598","author":"Kaptein","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102424_bib67","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/266815a0","article-title":"Defective interfering particles with covalently linked [+\/-]RNA induce interferon","volume":"266","author":"Marcus","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102424_bib68","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1099\/0022-1317-56-1-175","article-title":"The characteristics required for a Sendai virus preparation to induce high levels of interferon in human lymphoblastoid cells","volume":"56","author":"Johnston","year":"1981","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omtn.2024.102424_bib69","doi-asserted-by":"crossref","first-page":"5713","DOI":"10.1016\/j.vaccine.2013.09.040","article-title":"Highly immunostimulatory RNA derived from a Sendai virus defective viral genome","volume":"31","author":"Mercado-Lopez","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2024.102424_bib70","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102424_bib71","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nbt.2614","article-title":"Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling","volume":"31","author":"Sahay","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102424_bib72","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal escape: A bottleneck for LNP-mediated therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102424_bib73","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid Nanoparticle Systems for Enabling Gene Therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102424_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2022.100450","article-title":"Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics","volume":"44","author":"Mukai","year":"2022","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.omtn.2024.102424_bib75","doi-asserted-by":"crossref","first-page":"12561","DOI":"10.1128\/JVI.06743-11","article-title":"Gamma interferon (IFN-gamma) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-alpha\/beta receptor-deficient mice","volume":"86","author":"Prestwood","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102424_bib76","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.micinf.2011.10.006","article-title":"The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use","volume":"14","author":"Perera","year":"2012","journal-title":"Microb. Infect."},{"key":"10.1016\/j.omtn.2024.102424_bib77","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12929-018-0482-9","article-title":"The monocyte-macrophage-mast cell axis in dengue pathogenesis","volume":"25","author":"Wan","year":"2018","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.omtn.2024.102424_bib78","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.omtn.2024.102424_bib79","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","article-title":"The Dual Nature of Type I and Type II Interferons","volume":"9","author":"Lee","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2024.102424_bib80","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1016\/j.vaccine.2011.03.038","article-title":"A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness","volume":"29","author":"Gunther","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2024.102424_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002230","article-title":"Interferon regulatory factor-1 (IRF-1) shapes both innate and CD8(+) T\u00a0cell immune responses against West Nile virus infection","volume":"7","author":"Brien","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2024.102424_bib82","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.4049\/jimmunol.165.7.3970","article-title":"Impaired IFN-gamma production in IFN regulatory factor-1 knockout mice during endotoxemia is secondary to a loss of both IL-12 and IL-12 receptor expression","volume":"165","author":"Salkowski","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtn.2024.102424_bib83","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1126\/science.8009222","article-title":"Involvement of the IRF-1 transcription factor in antiviral responses to interferons","volume":"264","author":"Kimura","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.omtn.2024.102424_bib84","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/viro.1999.9834","article-title":"Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection","volume":"261","author":"Dutia","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2024.102424_bib85","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1146\/annurev.immunol.19.1.623","article-title":"IRF family of transcription factors as regulators of host defense","volume":"19","author":"Taniguchi","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.omtn.2024.102424_bib86","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3389\/fimmu.2019.01019","article-title":"IRF1 Maintains Optimal Constitutive Expression of Antiviral Genes and Regulates the Early Antiviral Response","volume":"10","author":"Panda","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2024.102424_bib87","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0065-3527(08)60279-1","article-title":"Effects of defective interfering viruses on virus replication and pathogenesis in\u00a0vitro and in\u00a0vivo","volume":"40","author":"Roux","year":"1991","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.omtn.2024.102424_bib88","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0042-6822(66)90093-6","article-title":"Defective T particles of vesicular stomatitis virus. II. Biologic role in homologous interference","volume":"30","author":"Huang","year":"1966","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2024.102424_bib89","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0042-6822(80)90385-2","article-title":"Viral interference by defective particles of vesicular stomatitis virus measured in individual cells","volume":"104","author":"Sekellick","year":"1980","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2024.102424_bib90","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1128\/jvi.46.3.860-870.1983","article-title":"Analysis of extracellular West Nile virus particles produced by cell cultures from genetically resistant and susceptible mice indicates enhanced amplification of defective interfering particles by resistant cultures","volume":"46","author":"Brinton","year":"1983","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102424_bib91","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nature09489","article-title":"2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members","volume":"468","author":"Daffis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102424_bib92","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ni.1979","article-title":"Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5","volume":"12","author":"Zust","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omtn.2024.102424_bib93","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/veac063","article-title":"Evolution of ACE2-independent SARS-CoV-2 infection and mouse adaption after passage in cells expressing human and mouse ACE2","volume":"8","author":"Yan","year":"2022","journal-title":"Virus Evol."},{"key":"10.1016\/j.omtn.2024.102424_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2022.160163","article-title":"Warmer ambient air temperatures reduce nasal turbinate and brain infection, but increase lung inflammation in the K18-hACE2 mouse model of COVID-19","volume":"859","author":"Dumenil","year":"2023","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.omtn.2024.102424_bib95","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1089\/hum.2012.176","article-title":"A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T\u00a0cells","volume":"24","author":"Apolloni","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2024.102424_bib96","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/imm.13125","article-title":"Monocyte isolation techniques significantly impact the phenotype of both isolated monocytes and derived macrophages in\u00a0vitro","volume":"159","author":"Nielsen","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.omtn.2024.102424_bib97","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s11095-008-9766-1","article-title":"Development of a novel method for formulating stable siRNA-loaded lipid particles for in\u00a0vivo use","volume":"26","author":"Wu","year":"2009","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.omtn.2024.102424_bib98","doi-asserted-by":"crossref","DOI":"10.1128\/mSphereDirect.00190-17","article-title":"De Novo Generation and Characterization of New Zika Virus Isolate Using Sequence Data from a Microcephaly Case","volume":"2","author":"Setoh","year":"2017","journal-title":"mSphere"},{"key":"10.1016\/j.omtn.2024.102424_bib99","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.4049\/jimmunol.0902187","article-title":"A physiological function of inflammation-associated SerpinB2 is regulation of adaptive immunity","volume":"184","author":"Schroder","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtn.2024.102424_bib100","doi-asserted-by":"crossref","first-page":"9888","DOI":"10.1128\/JVI.00956-12","article-title":"Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock","volume":"86","author":"Rudd","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102424_bib101","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1099\/vir.0.045088-0","article-title":"Characterization of a model of lethal dengue virus 2 infection in C57BL\/6 mice deficient in the alpha\/beta interferon receptor","volume":"93","author":"Orozco","year":"2012","journal-title":"J.\u00a0Gen. Virol."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124003111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124003111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:25:11Z","timestamp":1762601111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253124003111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2162253124003111"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102424","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.04.23.590664","asserted-by":"object"}]},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing defective interfering particles and lipid nanoparticles for effective delivery of an anti-dengue virus RNA therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102424","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102424"}}